Skip to main content

Issuer news19

Market segment: XZAP


Filter news by type

15.10.2024. 13:24 – Inside information

Glucodent Ltd. has successfully completed the examination of the effect of the API on the growth and development (proliferation) of pathogenic bacteria in the oral cavity with positive results.

Download document

23.09.2024. 11:14 – Inside information

Glucodent Ltd. has successfully completed the examination of the effect of the API on the pH of artificial saliva. The results obtained show that the action of the API exceeds the initial goals set by the scientists involved in the development of the GLUCODENT© product.

Download document

31.07.2024. 12:42 – Inside information

Glucodent Ltd. and IQVIA have signed an agreement to develop a "Data Informed Protocol Assessment" for an oral pathology product in diabetics

Download document

15.07.2024. 16:29 – Inside information

Glucodent Ltd. has successfully synthesized various APIs to form the basis for further research on the medical product for treating oral pathology in diabetics.

Download document

17.07.2012. 14:46 – Općenita propisana informacija

19.06.2012. 15:32 – Inside and other information

Download document

18.06.2012. 14:55 – Općenita propisana informacija

Nexe grupa d.d. delivered notice on General Meeting to be held on 19.06.2012.

Download document

14.06.2012. 09:13 – Inside and other information

Download document

10.06.2011. 14:42 – Općenita propisana informacija

Nexe grupa d.d. delivered notice on General Meeting to be held on 15.06.2011.

Download document

21.04.2011. 13:58 – Inside and other information

Download document